Bristol-Myers Squibb Co (NYSE: BMY)
DRUGS - Drug Manufacturers - Major
Health Care
Stock price data as of
Closing price: $54.19
-
Support level$47.95
-
Resistance levelN/A
-
Beta0.6
-
RSI (14-day)71.2
- BMY is one of this month's top performers with a return of 18.0 percent, beating 90 percent of stocks in the S&P-100.
- Up 3.4 percent, BMY is one of this week's biggest gainers.
- Volatility is forecast to fall over the next month.
- BMY is above its 200-day moving average, providing a measure of support for long positions.
- With RSI > 70, BMY is overbought. Odds slightly favor a short-term price reversal.
- Price broke above prior resistance level - a short-term bullish signal.
| 52-week low | 52-week high | Price as % of range |
|---|---|---|
| $42.60 | $63.11 | 61.2% |
| 200 day | 50 day | 20 day | 10 day |
|---|---|---|---|
| $48.78 | $47.61 | $51.04 | $52.67 |
Value at risk (VaR)
There is an estimated 5% probability that the stock price will fall by more than VaR in time period.
-
In the next week7.9%
-
In the next month16.1%
-
In the next year59.7%
| Period | Value |
|---|---|
| Historical (5 year) | 23.7% |
| Last month | 28.4% |
| Current estimate | 29.0% |
| Next month forecast | 28.5% |